Related Experiment Video
Updated: Dec 26, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hypercoagulable State and Glycemic Control in Diabetic Patients with Malignancy
Sry Suryani Widjaja1, Muhammad O K Syahputra1, Almaycano Ginting2
1Biochemistry Department, Medical Faculty, Universitas of Sumatera Utara, Medan, Indonesia.
Poor glycemic control in diabetic patients with cancer is linked to a hypercoagulable state. This increases the risk of thrombosis, impacting morbidity and mortality in this vulnerable population.
Area of Science:
- Endocrinology
- Oncology
- Hematology
Background:
- Diabetes and malignancy are leading chronic diseases in developing nations, significantly increasing patient morbidity and mortality.
- Diabetes, characterized by hyperglycemia, is associated with an elevated thrombosis risk.
- Cancer is a major cause of death, with thrombosis being a frequent complication due to tumor-induced biological changes, abnormal vascularization, endothelial dysfunction, and inflammation.
Purpose of the Study:
- To investigate the relationship between a hypercoagulable state and glycemic control in diabetic patients diagnosed with malignancy.
Main Methods:
- A case-control study involving eighty diabetic patients (40 with malignancy).
- Data collected from private hospitals and clinics.
- Measurements included Hemoglobin A1c (HbA1c), blood glucose levels, and D-dimer levels.
Main Results:
- 45% of samples exhibited poor blood glucose control.
- Elevated D-dimer levels were observed in both diabetic and diabetic-with-malignancy groups.
- A significant correlation was found between HbA1c and D-dimer (p=0.046), and between blood glucose and age (p=0.017).
Conclusions:
- Chronic hyperglycemia exacerbates the risk of a hypercoagulable state.
- This heightened risk contributes to increased morbidity and mortality in diabetic patients with malignancy.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

